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Abstract: The effect of primaquine on the
enzymatic antioxidant defence mechanisms of
erythrocytes were determined by measuring
the activities of the below enzymes, before
and after 30 minutes of incubation of
hemolyzates with 1 mM primaquine at 37°C.
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Among the enzymes studied glucose-6phosphate dehydrogenase seemed the most
sensitive enzyme; 57 % and 78 % inhibition
at zero (due to the binding of primaquine to
NADP binding site) and 30 minutes of
incubation (due to the reactive oxygen
species), respectively. Catalase, superoxide
dismutase, and glutathione-S-transferase
were less sensitive to primaquine-derived
reactive oxygen species: 33, 11, and 0 %
inhibition at the time zero and 39, 27, and 4
%, at the end of 30 minutes of incubation.
Glutathione reductase and glutathione

Introduction
Primaquine (PQ), an 8-aminoquinoline, is the only
tissue schizontocide currently available for radical
treatment of malarial infections but, the usefulness of the
drug is limited due to its toxic side effects. For example,
PQ causes hemolytic anemia in glucose-6-phosphate
dehydrogenase (G6PD) deficient patients [1]. It has been
demonstrated that the interaction between PQ and
NADPH underlies many aspects of PQ toxicity. The
interaction between PQ and NADPH and the autooxidation of PQ result in the formation of reactive oxygen
species (ROS) which results in the oxidative alterations in
erythrocytes [2-5].
Erythrocytes contain enzymes and antioxidants which
protect them against the activated oxygen species:
hydrogen peroxide (H2O2), superoxide (O2.-), and hydroxyl
(. OH) radicals. These activated oxygen species are
generated within normal erythrocytes after the addition
of PQ and other oxidant drugs [6,7].

peroxidase were resistant to primaquinederived reactive oxygen species.
The Primaquine-mediated toxicity, in vivo,
due to the primaquine-NAD(P)H or/and
primaquine-glucose-6-phosphate dehydrogenase interaction, will cause damage and the
degree of the damage will depend on: i.
concentration of the drug, PQ; ii. incubation
period and; iii. the type of the system
affected. The study of the interaction of
reactive oxygen species with these enzymes,
will help to better understand the role of
protective enzyme systems in erythrocytes to
oxidative stress.
Key Words: Primaquine, inhibition, glucose6-phosphate dehydrogenase, catalase,
glutathione
peroxidase,
superoxide
dismutase, glutathione reductase, glutathione
transferase.

Superoxide is detoxified by superoxide dismutase
(SOD), by converting two molecules of superoxide to yield
one molecule each of O2 and H2O2 [6,7]. Catalase (CAT)
and glutathione peroxidase (GSH-Px) protect the red cell
against reactive oxygen species [8,9]. Glutathione
reductase (GSSGGR) is an important enzyme for the
regeneration of the most important reducing power of
the erythrocytes, glutathione (GSH) [10]. Glutathione Stransferase (GST) which catalyzes the reaction of GSH as
a nucleophile, with a variety of compounds bearing an
electrophilic center plays an important role in the
mercapturate pathway [11].
G6PD is the first enzyme of pentose phosphate
pathway and which accounts for the most of NADPH
synthesized in red cells. NADPH is necessary for both
glutathione redox cycle [12,13] and the protection of CAT
against inactivation by H2O2 [8].
There are several reports about the oxidative effect of
PQ in erythrocytes but, the number of the parameters
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measured in these studies are limited and the
interrelations of these parameters are usually not been
considered.
In order to reevaluate the oxidative effect of PQ on
the enzymes responsible for the protection of
erythrocytes against ROS, this study was performed. The
activities of G6PD, CAT, GSH-Px, SOD, GSSGGR, and GST,
before and after incubation of human erythrocytes with 1
mM PQ, for half an hour, at 37˚C, were determined.
Materials and Methods
Materials
Primaquine
(8-(4-methyl
buthylamino)-6methoxyquinoline), diphosphate salt; glucose-6phosphate, disodium salt; NADP+ , monosodium salt;
bovine serum albumin, EDTA (Ethylenediaminetetraacetic
acid), GSH, GSSG, 1-chloro-2,4-dinitrobenzene, and
xanthine oxidase were from the Sigma Chemical Co.,
USA. 2-Mercaptoethanol, CuCl2 and H2O2 were obtained
from BDH and The Hopkins and William Ltd., England,
respectively. All the other chemicals were analytical grade
and obtained from either Sigma or Aldrich, U.S.A.
Methods
Preparation of packed red cells and hemolyzates
for assays: Adult human venous blood (10 different
healthy staff ages between 25-30 years: 4 men and 6
women), was drawn into EDTA-treated tubes and packed
red cells were prepared washing with physiological serum
(3 times) to eliminate leucocytes and plateletes [14].
Different types of hemolyzates were prepared from
packed red cells according to the type of enzyme going to
be tested [14-16]. These hemolyzates were incubated
with 1 mM PQ (30 min, at 37˚C) and the activities of
G6PD, GSGGGR, GSH-Px were determined by adding an
aliquot of the enzyme from incubation medium to the
cuvette and the change in absorbance were monitored
[14]. CAT and SOD activities were measured by the
method of Aebi [15], and Sun et. al. [16], respectively. All
measurements were made on a Milton-Roy 3000
spectrophotometer.
Results and Discussion
Oxidant drugs increase oxidative stress in red blood
cells by generating free radicals and decreasing the
activities of antioxidant enzymes. It has been shown that
the oxidative effects of PQ have been the formation of a
charge transfer complex between PQ and (NAD[P])H, and
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auto-oxidation of PQ leading to the oxidation of the
reduced pyridine nucleotides and generation of ROS
(H2O2, O2.- , . OH) [2-4]. Thus, these observations explain
the various aspects of PQ toxicity in erythrocytes.
In the present study, erythrocyte hemolyzates were
incubated with 1 mM PQ, at 37˚C, for 30 minutes and the
effect of PQ on the activities of erythrocytes, G6PD, CAT,
SOD, GSH-Px, GSSGGR and GST, was determined.
Hemolyzates were used instead of intact erythrocytes
because, i. erythrocytes are hemolyzed by [PQ] ≥ 1 mM;
ii. entrance of PQ into erythrocytes is difficult (transport
problem). The effect of PQ on the activities of G6PD,
SOD, CAT, GSH-Px, GSSGGR, and GST in human
erythrocyte lyzates is summarized in the below Table.
It has been demonstrated that PQ reacts with NADPH
and this interaction lowered the cellular NADPH level
[2,4]. The 57% inhibition of G6PD, following 1 mM PQ
addition, could be explained by the binding of primaquine
to the NADP+ binding site on G6PD and additional 21%
inhibition, during 30 minutes incubation, might be due to
the oxidation of the two very reactive thiol groups
responsible for the activity of the enzyme [17,18].
In erythrocytes, it is possible that PQ exists in various
redox states and can form H2O2 either from the
dismutation of superoxide radicals or from the oxidation
of the NADPH:PQ complex by superoxide radicals, which
will cause the oxidation of NADPH [2] or thiols [18]. It
has been demonstrated that glucose partially maintains
NADPH concentration in the presence of PQ by increasing
the flux through the pentose monophosphate pathway
[19]. It has also been shown that the inhibition of G6PD
caused by PQ can be completely reversed by excess
NADP+ [20].
However, SOD and CAT were affected less from the
incubation of hemolyzates with the drug, PQ. Inhibitions
at zero and 30 minutes of incubation with PQ (1 mM,
37˚C) for SOD and CAT were; 33, 11 and 39, 27 per
cent, respectively (Table).
Among these three enzymes; SOD, is a Cu+2
dependent enzyme and it will be inactivated if the cupper
at the active of the enzyme is reduced to Cu+1 by H2O2.
No inactivation of SOD, in the presence of CAT, was
observed [21]. In this study, inhibition of SOD activity in
hemolyzates incubated with PQ, was observed. This
contradiction could easily be explained by the low
concentration of the PQ in earlier works. Here, the rate
of H2O2 production is probably much higher than its
consumption by endogenous CAT in the PQ-treated
erythrocyte lyzates.

M. MÜFTÜOĞLU, N. ÖZER

Enzymes

G6PD
(U/g Hb)
SOD
(U/mg protein)
Catalase
(k/g Hb)
GST
(U/g Hb)
GSSGGR (-FAD)
(U/g Hb)
GSSGGR (+FAD)
(U/g Hb)
GSH-Px
(U/g Hb)

Control
(-PO)

0 min
(+PQ)
% Inhibition

30 min
(+PQ)
% Inhibition

100 (12.99±1.31)

57 (5.62±1.43)*

78 (2.60±0.82)*

100 (217±29)

33 (146±48)*

39 (126±49)*

100 (291±30)

11(259±31)*

27 (201±20)*

100 (7.5±2.1)

0 (7.5±2.1)*

4 (7.2±2.0)*

100 (5.31±1.31)

0 (5.31±1.31)*

0 (5.31±1.31)*

100 (7.84±1.35)

0 (7.84±1.35)*

0 (7.84±1.35)*

100 (7.91±3.34)*

0 (7.91±3.34)*

0 (7.91±3.34)*

Table 1.

The Effect of PQ on the
Activities of G6PD, SOD, CAT,
GST, GSSGGR (±FAD) and
GSH-Px
in
Erythrocyte
Lyzates.

* Values in parenthesis are absolute values: Means±SD (n=10).

The second protective enzyme, CAT contains four
tightly bound molecules of NADPH which are not essential
for activity [8], but protects the enzyme against
inactivation by its substrate, H2O2 [9, 22, 23].
Glutathione-related enzymes, (GST, GSSGGR, GSHPx) are the least (or none) affected by ROS. Among these
enzymes only GST was sligthly inhibited (4%) by the
incubation with PQ for 30 min, at 37˚C. These enzymes
seem more resistant to oxidation by H2O2.
As a result we can say that the prooxidant drug PQ
causes some deleterious effects on the antioxidant

enzyme systems in erythrocytes. PQ-NAD[P]H interaction
might be responsible for the PQ-mediated toxicity, in
erythrocyte lyzates. The degree of the damage will
depend on: i. concentration of the drug, PQ; ii. incubation
period and; iii. the type of the system affected. A more
detailed study, using hemolyzates or drugs with no
transport problem or/and study which undertakes direct
interaction of ROS with these enzymes, will help to better
understand the role of protective systems in erythrocytes
against oxidative stress.
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